Ann: End-of-Treatment Milestone Met in Phase 2 PTSD Trial, page-6

I am not surprised.

As I said earlier, the company would have outsourced the trial to a specialist group.

They don't get told anything until all results are in and collated.

The company then has a window of time to assess the results and to inform the market.

If results are not pretty compelling or are not pretty clear, company may suspend trade while they do a more thorough evaluation and detailed announcement.

In light of today's announcement, I think we will know that results well before the end of the quarter.

It's time for the penalty shoot out.